Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Reumatismo ; 59(1): 57-65, 2007.
Article in Italian | MEDLINE | ID: mdl-17435843

ABSTRACT

Increasing amounts of data have recently been published regarding ultrasonographic (US) findings of osteoarthritic joints, but very few data concern hip joints. In the current study we described US patterns concerning 490 patients affected by symptomatic hip osteoarthritis (OA) who underwent to intra-articular injections of hyaluronic products under US guidance. All patients were studied by US and X-ray of hip, clinical evaluation was assessed by the followings indexes: Lequesne, pain VAS, ICED, Global Physician Assessment and Global Patient Assessment. US findings were summarized in four main patterns, effusion and synovial proliferation were also detected. The aim of this study was to correlate US findings with clinical assessment and radiographic findings (according to Kellgren-Lawrence classification). Pearson's r correlation coefficient were computed and come out significant and positive between X ray and US patterns and between clinical indexes and US patterns. Also the correlation between K-L score and US patterns showed a significant positive correlation indicating that higher K-L scores are associated with increasing abnormal US findings. Our data suggest that ultrasonography of the hip may give useful information about the state of synovial membrane, synovial fluid, joint margins and bone profile in hip OA. Further studies are needed to evaluate their prevalence in hip OA symptomatic and not-symptomatic patients and their correlation to treatment outcome.


Subject(s)
Osteoarthritis, Hip/diagnostic imaging , Adjuvants, Immunologic/therapeutic use , Adult , Aged , Aged, 80 and over , Algorithms , Female , Humans , Hyaluronic Acid/therapeutic use , Injections, Intra-Articular , Longitudinal Studies , Male , Middle Aged , Osteoarthritis, Hip/complications , Osteoarthritis, Hip/drug therapy , Pain/drug therapy , Pain/etiology , Pain Measurement , Radiography , Severity of Illness Index , Treatment Outcome , Ultrasonography
3.
Eur Rev Med Pharmacol Sci ; 9(6): 373-8, 2005.
Article in English | MEDLINE | ID: mdl-16479743

ABSTRACT

Polymyalgia rheumatica (PMR) is a chronic inflammatory condition of the elderly, characterized by aching and morning stiffness in the cervical region, shoulders and pelvic girdles. A steroid treatment course of 6-24 months is often required, but, due to important side effects, it is troublesome if the PMR patient is also affected by diabetes mellitus (DM) and/or osteoporosis. Aim of our study is to test anti-TNF alpha treatment as a steroid sparing tool in PMR patients affected by DM or osteoporosis. In particular, we hypothesise that TNF alpha blockade can be useful not only in remission maintaining, but also in the induction of clinical remission without corticosteroids in this kind of patients. In a six months follow up, patients had clinical improvement, confirmed by physical medical examination, and a statistically significant reduction in ESR and CRP mean values. Anti-TNF alpha treatment was well tolerated by all patients. These preliminary data suggest than Infliximab can be useful in the treatment of PMR patients, not only for steroid sparing purposes, but also as first line therapy in PMR patients with severe comorbidity, such as diabetes mellitus or osteoporosis.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 2/complications , Osteoporosis/complications , Polymyalgia Rheumatica/drug therapy , Tumor Necrosis Factor-alpha/immunology , Aged , Aged, 80 and over , Antirheumatic Agents/therapeutic use , Female , Humans , Infliximab , Polymyalgia Rheumatica/complications , Remission Induction , Treatment Outcome , Tumor Necrosis Factor-alpha/antagonists & inhibitors
5.
Dig Dis Sci ; 46(6): 1305-12, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11414309

ABSTRACT

Sex mismatch is a well-known risk factor for chronic rejection of liver allografts, but the mechanisms involved remain unclear. Since experimental observations suggest that female liver is more sensitive to reperfusion injury than male liver, we assessed the influence of gender on oxidative stress. Livers from male and female rats were exposed to warm ischemia and reperfused by an oxygenated buffer. Chemiluminescence was continuously recorded. Reduced and oxidized glutathione and malondialdehyde lactic dehydrogenase values were also determined. Chemiluminescence increased during reperfusion in both groups, but was significantly greater in livers from female rats. Malondyaldehyde and lactic dehydrogenase progressively increased in all animals, reaching significantly greater values in female rats. Livers from female rats showed an increase in all the parameters of oxidative stress compared to male animals. A greater susceptibility to reperfusion injury may be evoked as an alternative mechanism to explain the poor outcome of female organ after liver transplantation.


Subject(s)
Liver Diseases/etiology , Reperfusion Injury/etiology , Animals , Female , Liver Diseases/pathology , Luminescent Measurements , Male , Rats , Rats, Wistar , Reperfusion Injury/pathology , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...